Press Release Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update 2 hours ago
Press Release Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA’s 503A Bulks List, Including BPC-157, TB-500 and MOTS-c Jul 28